Market Tracker

03/29 9:03am ET

Mesoblast Ltd (NASDAQ:MESO)

9.50
Delayed Data
As of Mar 28
 +0.85 / +9.83%
Today’s Change
3.50
Today|||52-Week Range
9.95
+77.57%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close8.65
Today’s open8.53
Day’s range8.53 - 9.50
Volume33,166
Average volume (3 months)20,636
Market cap$756.6M
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-487.72%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
OFIXOrthofix Internation...-0.06-0.15%
IVCInvacare Corp-0.25-2.12%
ITGRInteger Holdings Cor...+0.80+2.10%
CFMSConforMIS Inc-0.19-3.64%
Data as of 03/28/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts